R. M. Strieter
Robert M. Strieter is currently the Henry B. Mulholland Professor of medicine and the Chair of the Department of Medicine at the University of Virginia School of Medicine. He received his undergraduate education at the University of Michigan, and his medical degree from the College of Human Medicine, Michigan State University. Dr. Strieter did his internship, residency, and chief residency at St. Joseph Mercy Hospital, Ann Arbor, Mich, USA. He performed his fellowship in pulmonary and critical care medicine at the University of Michigan Medical Center. He subsequently became an Assistant Professor, Associate Professor, and Professor with tenure at the University of Michigan. In 2000, he assumed the position of the Chief of the Division of Pulmonary and Critical Care Medicine, and then became the Vice Chair of the Department of Medicine for Hospitalist programs at the David Geffen School of Medicine at UCLA. He subsequently moved to the University of Virginia in July 2006 to assume the position of the Chair of the Department of Medicine. Additionally, he has pivotal publications in the field of inflammation, immunology, and angiogenesis related to cytokine and chemokine biology. His laboratory was the first to demonstrate that chemokines were expressed by nonleukocyte cellular populations. Moreover, his laboratory discovered a novel paradigm for the role of CXC chemokines in the regulation of angiogenesis. He also determined that the CXC chemokine family was a unique family of cytokines that displayed disparate activity in the regulation of angiogenesis. Dr. Strieter’s laboratory has identified the importance of a circulating cell, referred to as fibrocytes that are bone marrow-derived mesenchymal stem cells that traffic and home to the lung; and contribute to the fibroproliferative response to injury. These findings provide a new paradigm for the pathogenesis of fibroproliferative disorders in the lung.
Biography Updated on 4 September 2008